Age, sex | Mutation | VCE finding* | Location | Procedure | Final diagnosis |
---|---|---|---|---|---|
52, M | MSH2 | Thickened fold | Duodenum | Gastroduodenoscopy | Adenocarcinoma |
61, M | MSH6 | Polyp <5 mm | Duodenum | Gastroduodenoscopy | Tubulovillous adenoma |
52, F | MSH6 | Polyp <5 mm | Jejunum | DBE antegrade | No abnormalities |
46, F | MSH2 | Polyp 6–9 mm | Jejunum | DBE retrograde and antegrade | No abnormalities |
57, M | MLH1 | Polyp <5 mm | Duodenum | DBE antegrade | Lymfoid hyperplasia |
44, F | MLH1 | Polyp 6–9 mm | Duodenum | Gastroduodenoscopy | Brunner's gland |
48, M | MLH1 | Polyp <5 mm | Duodenum | Gastroduodenoscopy | Brunner's gland |
39, M | MSH6 | Lymphoid hyperplasia | Jejunum | DBE antegrade | No abnormalities |
40, M | MLH1 | Polyp <5 mm | Jejunum | DBE antegrade | No abnormalities |
61, M | MSH6 | Polyp <5 mm | Jejunum | DBE antegrade | No abnormalities |
37, F | MLH1 | Polyp 6–9 mm | Jejunum | Gastroduodenoscopy | No abnormalities |
60, M | MSH6 | Polyp 6–9 mm | Duodenum | Gastroduodenoscopy | Inflammation tissue |
40, M | MLH1 | Polyp 10 mm | Duodenum | Gastroduodenoscopy | Heterotopic gastric mucosa |
54, F | MLH1 | Haematin pigmentation | Duodenum | Gastroduodenoscopy | No abnormalities |
40, M | MSH2 | Polyp <5 mm | Duodenum | Gastroduodenoscopy | No abnormalities |
54, F | MSH6 | Polyp <5 mm | Stomach | Gastroduodenoscopy | No abnormalities |
38, F | MSH6 | Polyp 10 mm Polyp <5 mm | Duodenum Jejunum | MRI enteroclysis | No abnormalities |
*According to the Paris Classification.
DBE, double balloon enteroscopy; VCE, video capsule endoscopy.